# Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-for-patients-with-refractory-or-relapsed-thymic-epithelial-tumor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jinhyun Cho,Hae Su Kim,Bo Mi Ku,Yoon‐La Choi,Răzvan Cristescu,Joungho Han,Jong‐Mu Sun,Se‐Hoon Lee,Jin Seok Ahn,Keunchil Park,Myung‐Ju Ahn |
| Citations | 346 |
| DOI | 10.1200/jco.2017.77.3184 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.77.3184 |
| OpenAlex ID | https://openalex.org/W2808003286 |
| PMID | 29906252 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Se‐Hoon Lee](https://scholariq.org/researchers/se-hoon-lee/)
- [Yoon‐La Choi](https://scholariq.org/researchers/yoon-la-choi/)
- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn/)
- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [Myung‐Ju Ahn](https://scholariq.org/researchers/myung-ju-ahn/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Paper topics

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Adrenal Hormones and Disorders](https://scholariq.org/topics/adrenal-hormones-and-disorders/)
- [Lymphatic Disorders and Treatments](https://scholariq.org/topics/lymphatic-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.